The Rise of HV.1: A Dominant COVID Variant Emerges
TL;DR
The HV.1 variant of COVID-19 has become the dominant strain circulating in the United States, accounting for over a quarter of reported cases. Experts suggest that HV.1 may be more transmissible and have the potential to bypass prior immunity. However, there is no evidence yet that it causes more severe infections. The new COVID boosters from Pfizer and Moderna, designed to target XBB variants, are expected to offer some protection against HV.1. However, the uptake of the updated boosters has been low, with only 3.5% of the U.S. population receiving them. The CDC recommends the updated shots for everyone six months and older.
- A New, Dominant COVID Variant Is Circulating: Here's What We Know The Messenger
- What you need to know about HV.1, the new COVID-19 variant dominating cases in the U.S. Deseret News
- HV1 COVID strain becomes dominant subvariant 10 Tampa Bay
- CDC weighs in on JN.1 COVID-19 variant developments University of Minnesota Twin Cities
- Has the winter COVID variant arrived? Here's why experts are closely monitoring the JN.1 strain Salon
Want the full story? Read the original reporting
Read on The Messenger